Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer CellsKyu Sic You, Yeon‐Sun Seong|Cancers|2021Cited by 37
Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cellsKyu Sic You, Yeon‐Sun Seong|International Journal of Oncology|2018Cited by 34